首页> 外文期刊>American Journal of Physiology >Increasing oxidative stress with molsidomine increases blood pressure in genetically hypertensive rats but not normotensive controls.
【24h】

Increasing oxidative stress with molsidomine increases blood pressure in genetically hypertensive rats but not normotensive controls.

机译:倍他宁胺增加氧化应激会增加遗传性高血压大鼠的血压,而不会使血压正常的对照组的血压升高。

获取原文
获取原文并翻译 | 示例
           

摘要

Spontaneously hypertensive rats (SHR) have a higher level of oxidative stress and exhibit a greater depressor response to a superoxide scavenger, tempol, than normotensive Wistar-Kyoto rats (WKY). This study determined whether an increase in oxidative stress with a superoxide/NO donor, molsidomine, would amplify the blood pressure in SHR. Male SHR and WKY were given molsidomine (30 mg.kg(-1).day(-1)) or vehicle (0.01% ethanol) for 1 wk, and blood pressure, renal hemodynamics, nitrate and nitrite excretion (NOx), renal superoxide production, and expression of renal antioxidant enzymes, Mn- and Cu,Zn-SOD, catalase, and glutathione peroxidase (GPx), were measured. Renal superoxide and NOx were higher in control SHR than in WKY. Molsidomine increased superoxide by approximately 35% and NOx by 250% in both SHR and WKY. Mean arterial blood pressure (MAP) was also higher in control SHR than WKY. Molsidomine increased MAP by 14% and caused renal vasoconstriction in SHR but reduced MAP by 16%, with no effect onrenal hemodynamics, in WKY. Renal expression of Mn- and Cu,Zn-SOD was not different between SHR and WKY, but expression of catalase and GPx were approximately 30% lower in kidney of SHR than WKY. The levels of Mn- and Cu,Zn-SOD were not increased with molsidomine in either WKY or SHR. Renal catalase and GPx expression was increased by 300-400% with molsidomine in WKY, but there was no effect in SHR. Increasing oxidative stress elevated blood pressure further in SHR but not WKY. WKY are likely protected because of higher bioavailable levels of NO and the ability to upregulate catalase and GPx.
机译:与正常血压的Wistar-Kyoto大鼠(WKY)相比,自发性高血压大鼠(SHR)的氧化应激水平更高,并且对超氧化物清除剂tempol的抑制作用更大。这项研究确定了超氧化物/ NO供体莫斯多明对氧化应激的增加是否会放大SHR中的血压。男性SHR和WKY分别服用莫斯多明(30 mg.kg(-1).day(-1))或媒介物(0.01%乙醇)1周,血压,肾脏血流动力学,硝酸盐和亚硝酸盐排泄(NOx),肾脏测量了超氧化物的产生,以及肾脏抗氧化酶,锰和铜,锌超氧化物歧化酶,过氧化氢酶和谷胱甘肽过氧化物酶(GPx)的表达。对照SHR中的肾脏超氧化物和NOx高于WKY。在SHR和WKY中,莫西多胺使超氧化物增加约35%,NOx增加250%。对照SHR中的平均动脉血压(MAP)也高于WKY。在WKY中,莫西多明使MAP增加14%,并引起SHR的肾血管收缩,但使MAP减少16%,对肾血流动力学没有影响。 SHR和WKY之间的Mn-和Cu,Zn-SOD肾表达无差异,但是SHR肾脏中过氧化氢酶和GPx的表达比WKY低30%。在WKY或SHR中,molsidomine不会增加Mn-和Cu,Zn-SOD的水平。在WKY中,molsidomine可使肾脏过氧化氢酶和GPx表达增加300-400%,但对SHR无影响。 SHR中氧化应激的增加进一步使血压升高,但WKY则没有。 WKY可能受到保护,因为NO的生物利用率较高,并且具有上调过氧化氢酶和GPx的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号